No Data
Insmed Q1 2024 GAAP EPS $(1.06) Beats $(1.23) Estimate, Sales $75.500M Miss $77.758M Estimate
Insmed (NASDAQ:INSM) reported quarterly losses of $(1.06) per share which beat the analyst consensus estimate of $(1.23) by 13.82 percent. This is a 9.4 percent increase over losses of $(1.17) per sha
Express News | Insmed Inc - Reiterates 2024 Global Arikayce Revenue Guidance in Range of $340 Mln to $360 Mln
Insmed | 10-Q: Quarterly report
Express News | Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update
Express News | Insmed Q1 Revenue USD 75.5 Million Vs. Ibes Estimate USD 77.8 Million
Express News | Insmed Outlook FY Revenue USD 340-360 Million